The trial of a Carievale, Sask., man charged with abducting his daughter ended Friday with a jury finding him guilty. Court heard Michael Gordon Jackson failed to return his seven-year-old ...

Jackson, who represented himself at the trial in Regina Court of King's Bench, had told the jury his only intention was to prevent his daughter from getting the COVID-19 vaccine. Jackson said he ...

According to TIME, the unidentified patient, who had a blood disorder, was unable to develop a strong immunity to the virus after getting "multiple COVID shots before catching the Omicron variant ...

Coming Monday: One reason Schenectady officials say their kids are missing school The confluence ... “Chronic absenteeism increased during the COVID-19 pandemic at troubling rates, nearly ...

20-month-long SARS-CoV-2 infection is the longest known, according to the researchers A COVID-19 patient with a weakened immune system incubated a highly mutated novel strain over 613 days before ...

SHANGHAI/SUZHOU, China (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology ...

China's Drugmakers Can't Sell MRNA Shots but Haven't Quit Yet By Andrew Silver SHANGHAI/SUZHOU, China (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle ...

Jackson, who represented himself at the trial in Regina Court of King's Bench, had told the jury his only intention was to prevent his daughter from getting the COVID-19 vaccine. Jackson said he ...

The meeting date assigned by the FDA is June 7, 2024. The Company, under its wholly-owned subsidiary Revive Diagnostics Inc., is advancing the Product as a potential blood biomarker diagnostic that ...

Currently, there is no FDA-approved clinical diagnosis of long COVID and it is estimated to occur in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

Currently, there is no FDA-approved clinical diagnosis of long COVID and it is estimated to occur in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

The meeting date assigned by the FDA is June 7, 2024. The Company, under its wholly-owned subsidiary Revive Diagnostics Inc., is advancing the Product as a potential blood biomarker diagnostic that ...